These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 4005859)

  • 1. Presence of breast cancer antigens in uninvolved axillary lymph nodes.
    Hendler FJ; House D
    Cancer Res; 1985 Jul; 45(7):3364-73. PubMed ID: 4005859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of monoclonal antibody binding to estrogen and progesterone receptor content in breast cancer.
    Hendler FJ; Yuan D
    Cancer Res; 1985 Jan; 45(1):421-9. PubMed ID: 3965148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
    Nuti M; Castagna M; Squartini F
    Appl Pathol; 1984; 2(3):117-27. PubMed ID: 6085790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
    Morton BA; Ramey WG; Paderon H; Miller RE
    Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
    Mantovani G; Serri FG; Macciò A; Castelli P; Benedetti P; Scambia G; Santus S; Paderi R; Murtas MG; Ferreli A
    Cancer Detect Prev; 1989; 13(5-6):323-32. PubMed ID: 2743354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
    Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
    Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of mast cells in the axillary lymph nodes of breast cancer patients.
    Naik R; Baliga P; Bansal R; Pai M
    J Indian Med Assoc; 1997 Dec; 95(12):606-7. PubMed ID: 9586403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of monoclonal antibodies showing a different spectrum of reactivity to human breast tissue.
    Mandeville R; Giroux L; Lecomte J; Chausseau JP; Dumas F; Ajdukovic I; Vidal D; Boury F
    Cancer Detect Prev; 1987; 10(1-2):89-100. PubMed ID: 2436777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of the sentinel node in patients with breast carcinoma].
    Nieweg OE; Kapteijn BA; Peterse JL; Rutgers EJ; van Dongen JA; Kroon BB
    Ned Tijdschr Geneeskd; 1996 Nov; 140(45):2235-9. PubMed ID: 8984369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
    Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N
    Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human-human hybridomas and human monoclonal antibodies obtained by fusion of lymph node lymphocytes from breast cancer patients.
    Kjeldsen TB; Rasmussen BB; Rose C; Zeuthen J
    Cancer Res; 1988 Jun; 48(11):3208-14. PubMed ID: 3365703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.
    Gebauer G; Fehm T; Merkle E; Jaeger W; Mitze M
    Anticancer Res; 2003; 23(5b):4319-24. PubMed ID: 14666645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
    Diel IJ; Cote RJ
    Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of minute axillary lymph nodes to accurate staging for patients with breast cancer.
    Jiang J; He QQ; Yang XH; Liang Y; Fan LJ; Zhang Y; Guo MQ
    Chin Med J (Engl); 2007 Oct; 120(20):1762-5. PubMed ID: 18028767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro studies of axillary lymph node cells in patients with breast cancer.
    Tsakraklides E; Tsakraklides V; Ashikari H; Rosen PP; Siegal FP; Robbins GF; Good RA
    J Natl Cancer Inst; 1975 Mar; 54(3):549-56. PubMed ID: 1079055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of metastatic breast carcinoma with monoclonal antibodies to cytokeratins.
    Sedmak DD; Meineke TA; Knechtges DS
    Arch Pathol Lab Med; 1989 Jul; 113(7):786-9. PubMed ID: 2472784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.